SCHEMBL22689488

SCHEMBL22689488

Nc1cc(F)c(N2CC3CCSCCC3C2)c(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL238837 0.88 MAOA (0.32)
SCHEMBL239087 0.88 MAOA (0.32)
SCHEMBL241891 0.84 ALDH1A1 (0.32)
SCHEMBL241355 0.84 ALDH1A1 (0.32)
SCHEMBL22689408 0.78 SLC6A9 (0.32)
SCHEMBL22698727 0.78
SCHEMBL22698342 0.77 ALDH1A1 (0.38)
SCHEMBL3045642 0.77 GAA (0.44)
SCHEMBL23833818 0.75 GAA (0.43)
SCHEMBL4706606 0.74 MAOA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020234636-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF MAMMALIAN INFECTIONS CADILA HEALTHCARE LIMITED (IN) 2020-11-26 WO disclosed
WO-2020234636-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF MAMMALIAN INFECTIONS CADILA HEALTHCARE LIMITED (IN) 2020-11-26 WO disclosed